Oral Maxillofacial Head-Neck Key Laboratory of Medical Biology, and central laboratory of Liaocheng People's Hospital, Liaocheng, Shandong, 252000, China.
Department of Oral and Maxillofacial Surgery, Liaocheng People's Hospital and Clinical School of Taishan Medical University, Liaocheng, Shandong, 252000, China.
Biomed Pharmacother. 2018 Sep;105:566-572. doi: 10.1016/j.biopha.2018.06.001. Epub 2018 Jun 8.
Squamous cell carcinoma is often associated with the deletion or mutation of zinc finger protein 750 (ZNF750), its deletion or mutation is associated with squamous epithelial malignant biological characteristics. The present study is to explore the mechanism of ZNF750 to suppress the tumor malignant process by regulation tumor microenvironment.
To evaluate the changes of tumor microenvironment in oral squamous cells carcinoma cell line CAL-27 cell, the expression of angiogenin, vascular endothelial growth factor (VEGF), prolyl hydroxylase 2 (PHD2), G protein signal regulated protein 5 (RGS5), integrin A5 (ITGA5), integrin B1 (ITGB1) and CD44 were detected by Western-blot. The changes of platelet derived growth factor (PDGFB) and tumor vascular marker CD105 (Endoglin) mRNA were estimated by qPCR. The effect of over-expressed ZNF750 on cell viability and lateral migration capacity was investigated by CCK-8 and cell scratch assay in three oral squamous cells carcinoma.
ZNF750 could effectively inhibit the protein or mRNA expression of angiogenin, VEGF, RGS5 and CD105, repressed the cell adhesion molecules ITGA5, ITGB1 and CD44, but up-regulate the protein or mRNA expression of PHD2 and PDGFB. The cell viability and lateral migration ability of three oral squamous cells carcinoma were reduced by over-expression of ZNF750.
ZNF750 could modulate the tumor vascular microenvironment to inhibit the oral squamous cells carcinoma malignant progression.
鳞状细胞癌常与锌指蛋白 750(ZNF750)的缺失或突变相关,其缺失或突变与鳞状上皮恶性生物学特征有关。本研究旨在探讨 ZNF750 通过调节肿瘤微环境来抑制肿瘤恶性进程的机制。
为了评估口腔鳞状细胞癌细胞系 CAL-27 细胞中肿瘤微环境的变化,通过 Western blot 检测血管生成素、血管内皮生长因子(VEGF)、脯氨酰羟化酶 2(PHD2)、G 蛋白信号调节蛋白 5(RGS5)、整合素 A5(ITGA5)、整合素 B1(ITGB1)和 CD44 的表达。通过 qPCR 评估血小板衍生生长因子(PDGFB)和肿瘤血管标志物 CD105(内皮因子)mRNA 的变化。通过 CCK-8 和细胞划痕实验研究三种口腔鳞状细胞癌中过表达 ZNF750 对细胞活力和侧向迁移能力的影响。
ZNF750 能有效抑制血管生成素、VEGF、RGS5 和 CD105 的蛋白或 mRNA 表达,抑制细胞黏附分子 ITGA5、ITGB1 和 CD44,但上调 PHD2 和 PDGFB 的蛋白或 mRNA 表达。过表达 ZNF750 降低了三种口腔鳞状细胞癌的细胞活力和侧向迁移能力。
ZNF750 可以调节肿瘤血管微环境,抑制口腔鳞状细胞癌的恶性进展。